Correlation of rabbit antithymocyte globulin serum levels and clinical outcomes in children who received hematopoietic stem cell transplantation from an alternative donor
暂无分享,去创建一个
Y. Okuno | S. Kojima | H. Muramatsu | Yoshiyuki Takahashi | Yuka Torii | Yoshinori Ito | A. Narita | N. Kawashima | A. Hama | Yinyan Xu | Y. Sekiya | Xinan Wang | O. Ismael | Shaimaa Elmahdi | Yuko Sekiya
[1] A. Bacigalupo. How I treat acquired aplastic anemia. , 2017, Blood.
[2] A. Webster,et al. Post-transplant lymphoproliferative disorders , 2016, Nature Reviews Disease Primers.
[3] M. Mohty,et al. Rabbit anti-T cell globulin in allogeneic hematopoietic cell transplantation. , 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[4] M. Hosoya,et al. T-cell-replete haploidentical stem cell transplantation is highly efficacious for relapsed and refractory childhood acute leukaemia , 2014, Transfusion medicine.
[5] Y. Kanda,et al. Investigation of the freely available easy-to-use software ‘EZR' for medical statistics , 2012, Bone Marrow Transplantation.
[6] M. Remberger,et al. Effects of different serum-levels of ATG after unrelated donor umbilical cord blood transplantation. , 2012, Transplant immunology.
[7] M. Martelli,et al. Haploidentical hematopoietic transplantation: current status and future perspectives. , 2011, Blood.
[8] J Storek,et al. High incidence of post transplant lymphoproliferative disorder after antithymocyte globulin-based conditioning and ineffective prediction by day 28 EBV-specific T lymphocyte counts , 2011, Bone Marrow Transplantation.
[9] J. Stoltz,et al. The clinical value of concomitant Epstein Barr virus (EBV)-DNA load and specific immune reconstitution monitoring after allogeneic hematopoietic stem cell transplantation. , 2011, Transplant immunology.
[10] H. Einsele,et al. Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trial. , 2009, The Lancet. Oncology.
[11] M. Remberger,et al. Low serum levels of total rabbit-IgG is associated with acute graft-versus-host disease after unrelated donor hematopoietic stem cell transplantation: results from a prospective study. , 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[12] E. Jaffe,et al. Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation. , 2009, Blood.
[13] Q. Jiang,et al. Haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for treatment of hematological malignancies in children. , 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[14] P. Bruzzi,et al. Thymoglobulin prevents chronic graft-versus-host disease, chronic lung dysfunction, and late transplant-related mortality: long-term follow-up of a randomized trial in patients undergoing unrelated donor transplantation. , 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[15] H. Deeg,et al. Reduced incidence of acute and chronic graft-versus-host disease with the addition of thymoglobulin to a targeted busulfan/cyclophosphamide regimen. , 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[16] T. Klingebiel,et al. Experiences with haploidentical stem cell transplantation in children with acute lymphoblastic leukemia. , 2005, Pathologie-biologie.
[17] M. Remberger,et al. Rabbit-immunoglobulin G levels in patients receiving thymoglobulin as part of conditioning before unrelated donor stem cell transplantation. , 2005, Haematologica.
[18] T. Klingebiel,et al. Long-term outcome after haploidentical stem cell transplantation in children. , 2004, Blood cells, molecules & diseases.
[19] S. Sakaguchi,et al. CD4+ Tregs and immune control. , 2004, The Journal of clinical investigation.
[20] M. Remberger,et al. Dose Study of Thymoglobulin During Conditioning for Unrelated Donor Allogeneic Stem-Cell Transplantation , 2004, Transplantation.
[21] D. Blaise,et al. Graft-versus-host disease following allogeneic transplantation from HLA-identical sibling with antithymocyte globulin-based reduced-intensity preparative regimen. , 2003, Blood.
[22] T. Klingebiel,et al. Megadose transplantation of highly purified haploidentical stem cells: current results and future prospects , 2003, Pediatric transplantation.
[23] Y. Kodera,et al. Outcome of 154 patients with severe aplastic anemia who received transplants from unrelated donors: the Japan Marrow Donor Program. , 2002, Blood.
[24] P. Bruzzi,et al. Antithymocyte globulin for graft-versus-host disease prophylaxis in transplants from unrelated donors: 2 randomized studies from Gruppo Italiano Trapianti Midollo Osseo (GITMO). , 2001, Blood.
[25] K. Horibe,et al. Prospective monitoring of the Epstein–Barr virus DNA by a real‐time quantitative polymerase chain reaction after allogenic stem cell transplantation , 2001, British journal of haematology.
[26] T. Klingebiel,et al. Megadose transplantation of purified peripheral blood CD34+progenitor cells from HLA-mismatched parental donors in children , 2001, Bone Marrow Transplantation.
[27] A. Yoshimi,et al. Long‐term outcome of acquired aplastic anaemia in children: comparison between immunosuppressive therapy and bone marrow transplantation , 2000, British journal of haematology.
[28] D. Margolis,et al. Alternative-donor hematopoietic stem-cell transplantation for severe aplastic anemia. , 2000, Seminars in hematology.
[29] E. Jaffe,et al. Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study. , 1999, Blood.
[30] J. Hermans,et al. Risk factors for developing EBV-related B cell lymphoproliferative disorders (BLPD) after non-HLA-identical BMT in children. , 1996, Bone marrow transplantation.
[31] D. M. Hamlin,et al. COMPARATIVE POLYCLONAL ANTITHYMOCYTE GLOBULIN AND ANTILYMPHOCYTE/ANTILYMPHOBLAST GLOBULIN ANTI‐CD ANTIGEN ANALYSIS BY FLOW CYTOMETRY , 1995, Transplantation.
[32] J. Thomas,et al. A comprehensive definition of the major antibody specificities in polyclonal rabbit antithymocyte globulin. , 1994, Transplantation.
[33] J. Hansen,et al. Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program. , 1993, The New England journal of medicine.
[34] G. Heller,et al. Immune reconstitution following bone marrow transplantation: comparison of recipients of T-cell depleted marrow with recipients of conventional marrow grafts. , 1989, Blood.
[35] E. Gluckman,et al. Bone marrow transplantation for severe aplastic anemia from donors other than HLA identical siblings: a report of the BMT Working Party. , 1988, Bone marrow transplantation.
[36] M. Zutter,et al. Epstein-Barr virus lymphoproliferation after bone marrow transplantation. , 1988, Blood.